Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7255 results

Sort By:

Feasibility of Screening for Early Late Effects of Contemporary Therapy in High-Risk Neuroblastoma Survivors

Study ID: NCT06480526
Start Date: 2024-10-21
End Date: 2028-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

45

Intervention / Treatment
Sponsor

St. Jude Children's Research Hospital

Source: clinicaltrials.gov

Share:
Add to list

Molecular Epidemiology of Pediatric Germ Cell Tumors

Study ID: NCT05564026
Start Date: 2023-04-12
End Date: 2027-06-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1151

Intervention / Treatment

Administration questionnaire

Tumor Specimen Collection

Germline DNA Samples

Blood Sample Collection

Sponsor

Children's Oncology Group

Source: clinicaltrials.gov

Share:
Add to list

PRE-I-SPY Phase I/Ib Oncology Platform Program

Study ID: NCT05868226
Start Date: 2023-02-15
End Date: 2029-12-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

124

Intervention / Treatment

ALX148

Fam-Trastuzumab Deruxtecan-Nxki

Zanidatamab

Tucatinib

Sponsor

QuantumLeap Healthcare Collaborative

Source: clinicaltrials.gov

Share:
Add to list

Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer

Study ID: NCT04464226
Start Date: 2020-10-20
End Date: 2028-06-26
Study Type

Interventional

Study Phase

Phase3

No. of Participants

402

Intervention / Treatment

Darolutamide (Nubeka, Bay1841788)

Sponsor

Bayer

Source: clinicaltrials.gov

Share:
Add to list

Comprehensive Optimization At-time of Radical Cystectomy Intervention

Study ID: NCT05714826
Start Date: 2024-04-25
End Date: 2026-08-24
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

194

Intervention / Treatment

Preop Intervention and Monitored Recovery

Usual Care

Sponsor

University of Texas Southwestern Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Study ID: NCT05181826
Start Date: 2019-05-21
End Date: 2025-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1200

Intervention / Treatment

Multi-analyte Blood Test

Sponsor

Helio Genomics

Source: clinicaltrials.gov

Share:
Add to list

A Study of CRD3874-SI in People With Solid Tumors

Study ID: NCT06021626
Start Date: 2023-08-25
End Date: 2029-08
Study Type

Interventional

Study Phase

Phase1

No. of Participants

72

Intervention / Treatment

Clear 4

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer

Study ID: NCT02610426
Start Date: 2014-03-25
End Date: 2100-01-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

162

Intervention / Treatment

Laboratory Biomarker Analysis

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1 Study of NM6603 in Advanced Solid Tumors

Study ID: NCT06046066
Start Date: 2023-08-31
End Date: 2026-02-28
Study Type

Interventional

Study Phase

Phase1

No. of Participants

36

Intervention / Treatment

NM6603

Sponsor

NucMito Pharmaceuticals Co. Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer

Study ID: NCT06855524
Start Date: 2025-03-06
End Date: 2027-02-28
Study Type

Interventional

Study Phase

Phase2

No. of Participants

34

Intervention / Treatment

Biospecimen Collection

Oligo-fucoidan

Placebo Administration

Administration questionnaire

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list